Figure 7
From: In silico mutagenesis-based designing of oncogenic SHP2 peptide to inhibit cancer progression
All of the mutant peptide complexes (B–E) and the wild-type are depicted in the dynamics cross-correlation matrix in (A). This graph displays the number of residues produced by each system during the course of a 100 ns simulation.
